Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1073 | 942 | 1122 | 1149 | 1429 | 2389 |
Fund Return | 7.31% | -5.79% | 12.18% | 4.75% | 7.4% | 9.1% |
Place in category | 364 | 678 | 424 | 145 | 139 | 104 |
% in Category | 38 | 71 | 45 | 25 | 28 | 31 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust F Dist | 23.93K | 27.39 | 11.74 | 14.94 | ||
Legal General US Index Trust I Acc | 1.71B | 27.75 | 12.04 | 15.23 | ||
Legal General US Index Trust I Dist | 1.77B | 27.69 | 12.02 | 15.22 | ||
Legal General US Index Trust C Acc | 3.61B | 14.61 | 10.47 | 14.99 | ||
Legal General US Index Trust C Dist | 860.89M | 14.53 | 10.45 | 14.98 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 3.84B | 11.21 | 7.04 | 12.01 | ||
Wellington Global Health Care EquiG | 2.01B | 6.70 | 4.03 | 11.14 | ||
Global Health Care Fund W Acc GBP | 106.96M | 8.57 | 4.09 | 10.65 | ||
Adamant Medtech I GBP | 1.55B | 14.50 | 4.03 | 12.68 | ||
Pharmaceuticals Index Trust I Acc | 512.87M | 7.70 | 5.13 | 9.70 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.67 | 795.67 | -0.08% | |
UnitedHealth | US91324P1021 | 6.67 | 506.10 | -0.05% | |
J&J | US4781601046 | 4.97 | 145.85 | +0.40% | |
AbbVie | US00287Y1091 | 4.65 | 180.00 | +0.90% | |
Novo Nordisk B | DK0062498333 | 4.42 | 622.6 | +5.67% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review